Login to Your Account



Metabolon Raises $8M For Diagnostics Development

By Aaron Lorenzo


Thursday, January 26, 2006
Metabolon Inc., a low-key company specializing in biomarkers for drugs and diagnostics, raised $8 million in a Series B funding round that closed last week.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription